These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 2369097)

  • 21. Doxoform and Daunoform: anthracycline-formaldehyde conjugates toxic to resistant tumor cells.
    Fenick DJ; Taatjes DJ; Koch TH
    J Med Chem; 1997 Aug; 40(16):2452-61. PubMed ID: 9258351
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preparation, phototoxicity and biodistribution studies of anti-carcinoembryonic antigen monoclonal antibody-phthalocyanine conjugates.
    Carcenac M; Larroque C; Langlois R; van Lier JE; Artus JC; Pèlegrin A
    Photochem Photobiol; 1999 Dec; 70(6):930-6. PubMed ID: 10628305
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circumvention of resistance to daunorubicin by N-acetyldaunorubicin in Ehrlich ascites tumor.
    Skovsgaard T
    Cancer Res; 1980 Apr; 40(4):1077-83. PubMed ID: 7357538
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preparation of AHTG-DNR conjugates and their antitumor effect in vitro.
    Zhang DH; Tang JZ; Shen GX; Shu N; Zhu HF
    J Tongji Med Univ; 1990; 10(4):235-9. PubMed ID: 1711585
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of daunorubicin on cell growth, cell cycle and induction of apoptosis in HL-60 cells.
    Chikayama S; Kimura S; Kobayashi Y; Abe T; Maekawa T; Kondo M
    Haematologia (Budap); 1998; 29(2):115-21. PubMed ID: 9728803
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effects of daunorubicin on the expression of brain natriuretic peptide gene in myocardial cells: an in vitro experiment with cultured myocardial cells from rats].
    Wang CJ; Liu YL; Peng H
    Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(16):1144-6. PubMed ID: 17673002
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetic and cytotoxic studies of pegylated liposomal daunorubicin.
    Song H; Zhang J; Han Z; Zhang X; Li Z; Zhang L; Fu M; Lin C; Ma J
    Cancer Chemother Pharmacol; 2006 May; 57(5):591-8. PubMed ID: 16133530
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sensitization of human bladder cancer cells to Fas-mediated cytotoxicity by cis-diamminedichloroplatinum (II).
    Mizutani Y; Yoshida O; Bonavida B
    J Urol; 1998 Aug; 160(2):561-70. PubMed ID: 9679929
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of meta-tetrahydroxyphenylchlorin-monoclonal antibody conjugates for photoimmunotherapy.
    Vrouenraets MB; Visser GW; Stewart FA; Stigter M; Oppelaar H; Postmus PE; Snow GB; van Dongen GA
    Cancer Res; 1999 Apr; 59(7):1505-13. PubMed ID: 10197621
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of potent monoclonal antibody auristatin conjugates for cancer therapy.
    Doronina SO; Toki BE; Torgov MY; Mendelsohn BA; Cerveny CG; Chace DF; DeBlanc RL; Gearing RP; Bovee TD; Siegall CB; Francisco JA; Wahl AF; Meyer DL; Senter PD
    Nat Biotechnol; 2003 Jul; 21(7):778-84. PubMed ID: 12778055
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discovery of a daunorubicin analogue that exhibits potent antitumor activity and overcomes P-gp-mediated drug resistance.
    Fang L; Zhang G; Li C; Zheng X; Zhu L; Xiao JJ; Szakacs G; Nadas J; Chan KK; Wang PG; Sun D
    J Med Chem; 2006 Feb; 49(3):932-41. PubMed ID: 16451059
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Folate receptor targeted delivery of liposomal daunorubicin into tumor cells.
    Ni S; Stephenson SM; Lee RJ
    Anticancer Res; 2002; 22(4):2131-5. PubMed ID: 12174894
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Isomer-dependent daunomycin release and in vitro antitumour effect of cis-aconityl-daunomycin.
    Reményi J; Balázs B; Tóth S; Falus A; Tóth G; Hudecz F
    Biochem Biophys Res Commun; 2003 Apr; 303(2):556-61. PubMed ID: 12659854
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antitumor effect of anti-epidermal growth factor receptor monoclonal antibodies plus cis-diamminedichloroplatinum on well established A431 cell xenografts.
    Fan Z; Baselga J; Masui H; Mendelsohn J
    Cancer Res; 1993 Oct; 53(19):4637-42. PubMed ID: 8402640
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MGN-3/Biobran, modified arabinoxylan from rice bran, sensitizes human breast cancer cells to chemotherapeutic agent, daunorubicin.
    Gollapudi S; Ghoneum M
    Cancer Detect Prev; 2008; 32(1):1-6. PubMed ID: 18406070
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antitumor activity of T-2 toxin-conjugated monoclonal antibody to murine thymoma.
    Ohtani K; Murakami H; Shibuya O; Kawamura O; Ohi K; Chiba J; Otokawa M; Ueno Y
    Jpn J Exp Med; 1990 Apr; 60(2):57-65. PubMed ID: 2384978
    [TBL] [Abstract][Full Text] [Related]  

  • 37. STI571 combined with vincristine greatly suppressed the tumor formation of multidrug-resistant K562 cells in a human-nude mice xenograft model.
    Gao L; Chen L; Fei XH; Qiu HY; Zhou H; Wang JM
    Chin Med J (Engl); 2006 Jun; 119(11):911-8. PubMed ID: 16780770
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improvement of flow-cytometric detection of multidrug-resistant cells by cell-volume normalization of intracellular daunorubicin content.
    Ross DD; Thompson BW; Ordóñez JV; Joneckis CC
    Cytometry; 1989 Mar; 10(2):185-91. PubMed ID: 2714107
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Specific binding and internalization of monoclonal antibody HI98-daunorubicin conjugate by human leukemic cells (HL60).
    Liu J; Zhu Z; Liu J; Yin S; Chu Y; Qi S; Yang C; Chen Z
    Chin Med Sci J; 1991 Sep; 6(3):157-9. PubMed ID: 1793879
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytotoxic activity of daunorubicin or vindesin conjugated to a monoclonal antibody on cultured MCF-7 breast carcinoma cells.
    Aboud-Pirak E; Lesur B; Rao KS; Baurain R; Trouet A; Schneider YJ
    Biochem Pharmacol; 1989 Feb; 38(4):641-8. PubMed ID: 2917019
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.